Assessing the Causal Relationship Between Immune Cells and Temporomandibular Related Pain by Bi‐Directional Mendelian Randomization Analysis
Jianquan He,Xiayun Chen
DOI: https://doi.org/10.2147/jpr.s486817
IF: 2.8319
2024-11-23
Journal of Pain Research
Abstract:Jianquan He, Xiayun Chen Department of Stomatology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China Correspondence: Xiayun Chen, Department of Stomatology, The Third Affiliated Hospital, Sun Yat-Sen University, No. 600, TianHe Road, Guangzhou, Guangdong Province, 510630, People's Republic of China, Email Introduction: Even with significant progress has been made in elucidating the pathogenesis of temporomandibular disorders (TMD), the pathophysiology of temporomandibular joint (TMJ) pain is still obscure. Our study aimed to explore whether there is a causal link between immune cells and TMD-related pain. Materials and Methods: Based on the TMD-related pain data obtained from the FinnGen Research Consortium and the 731 immune traits extracted from the GWAS Catalog and utilized a two sample Mendelian Randomization (MR) method, with immune cell as the exposure and TMD-related pain as the outcome. MR analyses were conducted employing the inverse-variance weighting method (IVW) as the primary analytical method to evaluate the causal association. Sensitivity analyses were conducted to enhance the robustness, heterogeneity and horizontal pleiotropy of the results. A reverse MR analysis was also conducted for immune cell traits identified in the initial MR analysis. Results: After false discovery rate (FDR) correction, two immune traits were observed and found to be significantly associated with TMD-related pain: Hematopoietic Stem Cell absolute count (OR=0.954, 95% CI= 0.933~0.976), and HLA DR+ CD4+ T cell (OR=1.040, 95% CI=1.019~1.061). On the reverse MR analysis, no significantly associated results were found in causal effects of TMD-related pain on immune traits. Conclusion: Our study showed a potential causal relationship between immune cells and TMD-related pain, eliminating reverse causality. These discoveries significantly enhance our knowledge of the interaction between immune traits and TMD-related pain, opening new possibilities for designing treatment from an immunological perspective. Keywords: temporomandibular related pain, immune trait, immune cell, Mendelian randomization Temporomandibular disorders (TMD) encompass a range of medical and dental disorders that affect the function and health of the temporomandibular joints (TMJ), masticatory musculature and the accompanying structures, and are manifested by limitation of jaw movements, TMJ sounds like clicking and crepitus, as well as headaches and pain. 1 Various factors contribute to the development of TMD, including trauma to the joints and muscles, anatomical variations, psychosocial components, and the heightened sensitivity of nociceptive pathways. 2,3 Symptoms of TMD, especially pain, was considered to be a threatening stimulus in TMD patients, and generally associated with fatigue, mood and sleep disturbances, and poor quality of life. 4 Biomechanical and psychological signs and symptoms, often complicated by pain, tend to blur the fundamental cause(s) of the issue. Therefore, it is notoriously difficult to treat. Clinically, pain is often managed with symptomatic treatment, highlighting the need for more targeted treatments aimed at reducing or eliminating pain and enhancing the quality of life for these patients. 5 Previously, it has been thought that the production and perception of physiologic and clinical pain primarily reflects neuronal activity alone. However, it has become increasingly apparent that the majority of pain types either originate from or are shaped by the complicated interaction between the immune system and the somatosensory system. 6–8 It is considered that peripheral nociceptors can discern immune cells by recognizing the cytokines they secrete. Conversely, once activated, nociceptors release cytokines, neuropeptides, chemokines, and microRNAs from their terminals or cell bodies, thereby influencing resident immune cells such as neutrophils, macrophages, mast cells, and dendritic cells. 9,10 Extensive evidence indicates that specific pro-inflammatory cytokines, including TNF-α, IL-1, and IL-6, play a role in the development of pathological pain. 11–13 Additional studies have demonstrated that TNF-α is a key mediator of TMD-related pain, influencing both synaptic plasticity in central sensitization and the inflammatory pain response, which leads to increased nociceptive sensitization in periarticular tissues and trigeminal ganglia. 14,15 Therefore, pain needs to be recognized as a neuroimmune condition by considering neuroimmune interactions as integrative drivers and modulators, and not just a sign of inflammatory response. As an important element of the immune system, immune cells are the -Abstract Truncated-
clinical neurology